Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

Pharma company funding for patient advocacy groups needs to be transparent

By Joel Lexchin, Professor Emeritus of Health Policy and Management, York University, Canada
Patient advocacy groups are often funded through pharmaceutical companies, but there are currently no regulations governing disclosure of this potential conflict of interest.The Conversation


Read complete article

© The Conversation -
Subscribe to Tolerance.ca


Follow us on ...
Facebook Twitter